Systec Launches New and Improved HX-150 Autoclave at MEDICA 2019
|
By LabMedica International staff writers Posted on 18 Nov 2019 |

Illustration
Systec GmbH (Nuremberg, Germany) launched the first product from its re-designed Systec H-Series: the new and improved Systec HX-150 autoclave at the MEDICA 2019 International Trade Fair on November 18-21 in Düsseldorf, Germany. In addition to the new generation of autoclaves, visitors at MEDICA 2019 got a closer look at several other Systec devices, including not only autoclaves, but also advanced media preparators and the Systec Mediafill dispensing and dosing system. Systec’s partner company Evidencia GmbH also introduced innovative concepts for qualifying and validating equipment and sterilization processes.
MEDICA is the world's largest medical trade fair for medical technology, electromedical equipment, laboratory equipment, diagnostics and pharmaceuticals. More than 5,000 exhibitors from 70 countries presented their newest products and ideas at MEDICA 2019 which drew 120,000 trade visitors from over 170 countries.
The Systec H-Series floor-standing autoclaves of the performance category HX can be used for all laboratory applications, even for sophisticated sterilization processes and are available in 16 different sizes with 65 to 1580 liters chamber volume. All additional optional accessories can be fitted to obtain validatable processes. In spite of the high loading capacity, these autoclaves are compact and have a comparatively low weight.
The Systec HX-150 autoclave is the world’s first device from the new, improved Systec H-Series – a new generation of autoclaves in a new design, with a completely overhauled interior, and a touchscreen control that has been newly developed from scratch. This combination guarantees more precise work, easier to maintain equipment, and up to 25% faster autoclaving processes. In addition, the new autoclaves come with an Ethernet port as standard and optional Wi-Fi hardware to optimise updating processes, remote maintenance, and remote control of the devices via a computer network. An integrated USB port allows the automated export of documentation data in CSV or PDF format. The volume of the extended internal memory also allows storage of up to 10 years of documentation data. This eliminates the need for separate programs for documentation and archiving that are the otherwise necessary. This integrated documentation function is also interesting from a regulatory point of view, because the new generation of the Systec H- Series automatically fulfils an essential point of the FDA guideline 21 CFR Part 11. Additional features of the series also serve to satisfy regulatory requirements from the pharmaceutical industry, such as automatically distributed, tamper-proof signatures for the PDF and CSV files that are generated, and the tracking of all actions, adjustments, and alerts using AuditTrail.
Related Links:
Systec GmbH
MEDICA is the world's largest medical trade fair for medical technology, electromedical equipment, laboratory equipment, diagnostics and pharmaceuticals. More than 5,000 exhibitors from 70 countries presented their newest products and ideas at MEDICA 2019 which drew 120,000 trade visitors from over 170 countries.
The Systec H-Series floor-standing autoclaves of the performance category HX can be used for all laboratory applications, even for sophisticated sterilization processes and are available in 16 different sizes with 65 to 1580 liters chamber volume. All additional optional accessories can be fitted to obtain validatable processes. In spite of the high loading capacity, these autoclaves are compact and have a comparatively low weight.
The Systec HX-150 autoclave is the world’s first device from the new, improved Systec H-Series – a new generation of autoclaves in a new design, with a completely overhauled interior, and a touchscreen control that has been newly developed from scratch. This combination guarantees more precise work, easier to maintain equipment, and up to 25% faster autoclaving processes. In addition, the new autoclaves come with an Ethernet port as standard and optional Wi-Fi hardware to optimise updating processes, remote maintenance, and remote control of the devices via a computer network. An integrated USB port allows the automated export of documentation data in CSV or PDF format. The volume of the extended internal memory also allows storage of up to 10 years of documentation data. This eliminates the need for separate programs for documentation and archiving that are the otherwise necessary. This integrated documentation function is also interesting from a regulatory point of view, because the new generation of the Systec H- Series automatically fulfils an essential point of the FDA guideline 21 CFR Part 11. Additional features of the series also serve to satisfy regulatory requirements from the pharmaceutical industry, such as automatically distributed, tamper-proof signatures for the PDF and CSV files that are generated, and the tracking of all actions, adjustments, and alerts using AuditTrail.
Related Links:
Systec GmbH
Latest Medica 2019 News
- Mast Group Introduces New MAST CARBA PAcE for Rapid Carbapenemase Detection
- DRG Instruments Demonstrates DRG:HYBRID-XL Fully Automated Lab Analyzer
- Diatron Introduces New Aquila 5Dretic 5-Part Differential Hematology Analyzer
- Alifax S.r.l. Highlights First Automated System for Bacterial Culture and Susceptibility Testing
- Erba Mannheim Showcases New Launches at MEDICA 2019
- EUROIMMUN Showcases Immunoassay Testing Products at MEDICA 2019
- Diconex S.A. Exhibits InCCA Intelligent Clinical Chemistry Analyzer at MEDICA 2019
- Chembio Diagnostics Showcases New DPP Line of Rapid Tests at MEDICA 2019
- DYNEX Demonstrates DYNABLOT Automatic Analyzer for Immunoblot and Westernblot Methods
- TaiDoc Showcases Multi-Parameter Monitoring Systems and Advanced Devices
- IDS Exhibits Next Generation Automated Immunoanalyzer IDS-i10 at MEDICA 2019
- JEOL Ltd. Introduces BioMajesty Series of Clinical Chemistry Analyzers at MEDICA 2019
- EKF Diagnostics Showcases Full Product Range at MEDICA 2019
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Gut Microbiome Signatures Predict Long-Term Outcomes in Acute Pancreatitis
Severe acute pancreatitis is a life-threatening condition that often requires specialized interdisciplinary care and can lead to long-term complications. Many survivors later develop chronic or recurrent... Read more
Blood Test Could Identify High Risk Individuals for Type 2 Diabetes
Prediabetes is a highly heterogeneous metabolic condition, making it difficult to determine who will progress to type 2 diabetes or develop serious complications. While some individuals remain stable for... Read moreHematology
view channel
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channelAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
New Test Measures How Effectively Antibiotics Kill Bacteria
Antibiotics are typically evaluated by how well they inhibit bacterial growth in laboratory tests, but growth inhibition does not always mean the bacteria are actually killed. Some pathogens can survive... Read morePathology
view channel
AI Algorithms Improve Genetic Mutation Detection in Cancer Diagnostics
Accurately identifying genetic mutations is central to cancer diagnostics and genomic research, but current methods struggle with complex sequencing data and limited clinical samples. Tumor analysis often... Read more
Skin Biopsy Offers New Diagnostic Method for Neurodegenerative Diseases
Transthyretin amyloidosis (ATTR) is a rare, progressive, and highly aggressive disease caused by the misfolding of a specific protein that accumulates as toxic amyloid filaments in multiple organs.... Read moreTechnology
view channelAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channel
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more








